Status: Recruiting
Hormonal, Metabolic, and Signaling Interactions in PAH
Our hypothesis is that optimal treatment of the dysfunctional metabolic pathways which underlie PAH will improve pulmonary vascular function and consequences of the disease.
Participants needed: 1,899
Trial details
Age: Up to 90Biological sex: AllType: ObservationalSponsor: Vanderbilt University Medical CenterUpdated: Sep 16, 2025Locations: 1
Eligibility criteria
Diagnosis of IPAH (idiopathic pulmonary arterial hypertension), HPAH (heritable... [+15]